These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 17461779)

  • 21. mTOR phosphorylated at S2448 binds to raptor and rictor.
    Rosner M; Siegel N; Valli A; Fuchs C; Hengstschläger M
    Amino Acids; 2010 Jan; 38(1):223-8. PubMed ID: 19145465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity.
    Jacinto E; Facchinetti V; Liu D; Soto N; Wei S; Jung SY; Huang Q; Qin J; Su B
    Cell; 2006 Oct; 127(1):125-37. PubMed ID: 16962653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rictor is a novel target of p70 S6 kinase-1.
    Treins C; Warne PH; Magnuson MA; Pende M; Downward J
    Oncogene; 2010 Feb; 29(7):1003-16. PubMed ID: 19935711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous inhibition of mTORC1 and mTORC2 by mTOR kinase inhibitor AZD8055 induces autophagy and cell death in cancer cells.
    Sini P; James D; Chresta C; Guichard S
    Autophagy; 2010 May; 6(4):553-4. PubMed ID: 20364113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective interference of mTORC1/RAPTOR protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism with Akt and autophagy induction.
    Ito M; Yurube T; Kakutani K; Maeno K; Takada T; Terashima Y; Kakiuchi Y; Takeoka Y; Miyazaki S; Kuroda R; Nishida K
    Osteoarthritis Cartilage; 2017 Dec; 25(12):2134-2146. PubMed ID: 28888905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding.
    Wang L; Harris TE; Roth RA; Lawrence JC
    J Biol Chem; 2007 Jul; 282(27):20036-44. PubMed ID: 17510057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.
    Zhang X; Wang X; Xu T; Zhong S; Shen Z
    Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR.
    Yin Y; Hua H; Li M; Liu S; Kong Q; Shao T; Wang J; Luo Y; Wang Q; Luo T; Jiang Y
    Cell Res; 2016 Jan; 26(1):46-65. PubMed ID: 26584640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan.
    Lamming DW; Mihaylova MM; Katajisto P; Baar EL; Yilmaz OH; Hutchins A; Gultekin Y; Gaither R; Sabatini DM
    Aging Cell; 2014 Oct; 13(5):911-7. PubMed ID: 25059582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple site acetylation of Rictor stimulates mammalian target of rapamycin complex 2 (mTORC2)-dependent phosphorylation of Akt protein.
    Glidden EJ; Gray LG; Vemuru S; Li D; Harris TE; Mayo MW
    J Biol Chem; 2012 Jan; 287(1):581-588. PubMed ID: 22084251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2.
    Luo Y; Liu L; Wu Y; Singh K; Su B; Zhang N; Liu X; Shen Y; Huang S
    Oncotarget; 2015 Feb; 6(6):4286-98. PubMed ID: 25738366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The functions of mTOR in ischemic diseases.
    Hwang SK; Kim HH
    BMB Rep; 2011 Aug; 44(8):506-11. PubMed ID: 21871173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.
    Benavides-Serrato A; Lee J; Holmes B; Landon KA; Bashir T; Jung ME; Lichtenstein A; Gera J
    PLoS One; 2017; 12(4):e0176599. PubMed ID: 28453552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mTOR in growth and protection of hypertrophying myocardium.
    Balasubramanian S; Johnston RK; Moschella PC; Mani SK; Tuxworth WJ; Kuppuswamy D
    Cardiovasc Hematol Agents Med Chem; 2009 Jan; 7(1):52-63. PubMed ID: 19149544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rictor regulates cell migration by suppressing RhoGDI2.
    Agarwal NK; Chen CH; Cho H; Boulbès DR; Spooner E; Sarbassov DD
    Oncogene; 2013 May; 32(20):2521-6. PubMed ID: 22777355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional interaction of mammalian target of rapamycin complexes in regulating mammalian cell size and cell cycle.
    Rosner M; Fuchs C; Siegel N; Valli A; Hengstschläger M
    Hum Mol Genet; 2009 Sep; 18(17):3298-310. PubMed ID: 19505958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-induced endothelial proliferation requires both mTORC1 and mTORC2.
    Li W; Petrimpol M; Molle KD; Hall MN; Battegay EJ; Humar R
    Circ Res; 2007 Jan; 100(1):79-87. PubMed ID: 17110594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Rictor-Myo1c complex participates in dynamic cortical actin events in 3T3-L1 adipocytes.
    Hagan GN; Lin Y; Magnuson MA; Avruch J; Czech MP
    Mol Cell Biol; 2008 Jul; 28(13):4215-26. PubMed ID: 18426911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin.
    Zou Z; Chen J; Yang J; Bai X
    Curr Cancer Drug Targets; 2016; 16(4):288-304. PubMed ID: 26563881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alcohol-induced modulation of rictor and mTORC2 activity in C2C12 myoblasts.
    Hong-Brown LQ; Brown CR; Navaratnarajah M; Huber DS; Lang CH
    Alcohol Clin Exp Res; 2011 Aug; 35(8):1445-53. PubMed ID: 21438886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.